- Find
- Resources
Fda Approved Drugs For Prostate Cancer
The U.S. Food and Drug Administration (FDA) has approved the prostate cancer vaccine Provenge. Provenge does not cure cancer, but it has been shown to prolong the life of advanced prostate cancer patients by as much as four months. Experts say this is not a "one size fits all" vaccine--instead, it st tailored to each patient's particular type of tumor. The drug is also expensive, and can carry a price of $50,000 to $75,000.
More information on "Fda Approved Drugs For Prostate Cancer"
From Our Experts
Drugs Avodart, Proscar Rejected by FDA for Use as Prostate Cancer...
Drugs that fall into the category of 5-alpha reductase inhibitors (5 ARIs), such as Avodart (dutasteride) and Proscar (finasteride) have... Read more »
Blockbuster Osteoporosis Drug Moves Towards FDA Approval
Denosumab, a ground-breaking osteoporosis drug that’s been moving through clinical trials for several years, is set to take the first... Read more »
Cancer Drug, Avastin, Nears Approval
Avastin, a drug given conditional FDA approval for the treatment of metastatic breast cancer last February, is now one step closer to... Read more »
The F.D.A. approves MammaPrint® to Detect Chance of Breast Cancer...
An important first step has been taken in possibly cutting down the number of women who have to undergo chemotherapy for breast cancer. The... Read more »
FDA Approves REMS for Transmucosal Immediate-Release Fentanyl Meds
Since 2007, the FDA has been discussing and debating the development of Risk Evaluation and Mitigation Strategies (REMS) for opioid... Read more »
From Our Sources
FDA approves degarelix for advanced prostate cancer
The U.S. Food and Drug Administration has approved the injected drug degarelix for the treatment of advanced prostate cancer. The drug, which is a... Read more »
FDA approves new drug for advanced breast cancer
The Food and Drug Administration has approved Tykerb for use in advanced-stage breast cancer. Tykerb is used in patients who have advanced HER-2... Read more »
Rapaflo approved for enlarged prostate
The U.S. Food and Drug Administration has approved Rapaflo to treat enlarged prostate, or benign prostatic hyperplasia (BPH). The symptoms of BPH,... Read more »
FDA Revokes Approval for Avastin as Breast Cancer Treatment
The commissioner of the U.S. Food and Drug Administration has revoked the approval of Avastin as a breast cancer drug. In June, an FDA advisory... Read more »
FDA approves test to determine risk of cancer recurrence
The U.S. Food and Drug Administration has approved a test that helps assess the risk for cancer recurrence and long-term survival for patients with... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
